Sotalol

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Abarelix, Amiodarone, Amisulpride, Amitriptyline, Arsenic, Artemether/Lumefantrine, Asenapine, Astemizole, Atomoxetine, Bepridil, Ciprofloxacin, Class I and Class III antiarrhythmics, Clonidine, Degarelix, Disopyramide, Dronedarone, Droperidol, Enoxacin, Gatifloxacin, Guanethidine, Haloperidol, Insulin, Isoprenaline, Ivabradine, Levomepromazine, Lomefloxacin, Loop diuretics, Mizolastine, Moxifloxacin, Nilotinib, Norfloxacin, Ofloxacin, Oral macrolides, Phenothiazines, Pimavanserin, Pimozide, Procainamide, Quinidine, Quinine, Quinolones, Ranolazine, Reserpine, Ribociclib, Salbutamol, Sertindole, Sparfloxacin, Sulpiride, Terbutaline, Tetrabenazine, Thiazides and related diruetics, Tolterodine, Tricyclic antidepressants, Trifluoperazine, Vandetanib, Zuclopenthixol

PREGNANCY CATEGORY: B

Contra-indicated in patients with bronchial asthma, sinus bradycardia, second and third degree AV block, unless a functioning pacemaker is present, congenital or acquired long QT syndromes, cardiogenic shock, or uncontrolled congestive heart failure.

Our database has 52 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top